{
    "doi": "https://doi.org/10.1182/blood.V124.21.5455.5455",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=2733",
    "start_url_page_num": 2733,
    "is_scraped": "1",
    "article_title": "Pediatric Hodgkin\u2019s Lymphoma: 5-Year Experience at Single Center in Pakistan ",
    "article_date": "December 6, 2014",
    "session_type": "623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models",
    "topics": [
        "bleomycin/dacarbazine/doxorubicin/vinblastine protocol",
        "cancer",
        "chlorambucil/prednisone/procarbazine/vinblastine",
        "complete remission",
        "fever",
        "histopathology tests",
        "hodgkin's disease",
        "hodgkin's lymphoma, childhood",
        "night sweats",
        "pakistan"
    ],
    "author_names": [
        "Shazia Riaz, MD",
        "Safia Khan, MBBS, FCPS pediatrics",
        "Farhana Badar"
    ],
    "author_affiliations": [
        [
            "Shaukat Khanum Memorial Cancer Hospital and Research Center, LAHORE, Pakistan "
        ],
        [
            "Fellow Pediatric Oncology and hematology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan, Lahore, Pakistan "
        ],
        [
            "shaukat Khanum Hospital, Lahore, Pakistan"
        ]
    ],
    "first_author_latitude": "31.47975765",
    "first_author_longitude": "74.35667925",
    "abstract_text": "OBJECTIVES: To review patients\u2019 characteristics and treatment outcome pattern of pediatric hodgkinlympoma in a well funded center in developing country MATERIALS & METHOD: This was retrospective review of data of 301 pediatric hodgkin lymphoma patients up to 18 years of age treated in Shaukat Khanum Memeorial Cancer Hospital & Research Center, Lahore, Pakistan, during 2009 to 2013. RESULTS: Total No. of patients was 301, 81% were male. The median age of studied data was 9 years; ranging from 2 to 18 years. B symptoms in the form of fever, weight loss and night sweats were found in 51%, 29% and 34%, respectively. Median stage was 3 with neck bulky disease in 28% and Medistinal widening in 18% of patients. Trend of histopathology was mixed cellualrity at 56.5%. Most common treatment regime was ChlVPP/ABVD (59.5%); 30.6% of these 301 patient also got radiotherapy. At the end of treatment complete response was reported in 76.5%; 11.3% of these were relapsed afterward. CONCLUSION: Our data shows excellent outcome of pediatric hodgkin lympoma and results are comparable to that of developed countries. Disclosures No relevant conflicts of interest to declare."
}